Litecoin (LTC) has been persistently striving to break past the $135 resistance mark and is predicted by many to potentially hit the $200 in the near future. Meanwhile, the
CoinShares Spot Litecoin ETF awaits approval by the SEC, though there's been a postponement in the decision. Analysts suggest various cryptos including Litecoin might have ETFs in the pipeline. Despite the delay, LTC has shown signs of continued retail buying while whale activity seems to be declining. A remarkable development for the digital coin is its listing on UniLabs signaling an immense potential rally. In terms of institutional recognition,
MEI Pharma, a biotech company, has chosen Litecoin as its treasury asset, forecasting a positive investment climate for LTC. Consequent to this, LTC price surges 10% with prospects of reaching $105. LTC seems set for strong jumps, targeting $132-$145 by September 2025 in spite of bearish short-term momentum. Moreover,
Layer-2 Smart Contracts have been activated, providing Litecoin a fresh utility edge. Alongside analysis of LTC’s future pricing, there is also a bright outlook for the coin in terms of institutional interest till 2025. Finally, a
rare pattern observed predicts a $125 rebound for LTC.
LTC Coin News Analytics from Wed, 26 Feb 2025 08:00:00 GMT to Wed, 20 Aug 2025 19:10:56 GMT -
Rating 7
- Innovation 8
- Information 9
- Rumor 5
